Congress expands small-business R&D funding, tightens foreign-ownership rules

What it does

This bill reauthorizes and expands the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs through 2030, requiring federal agencies to gradually increase their R&D spending allocated to these programs from 4% to 7% by 2032. It adds new fellowship programs, improves commercialization pathways, enhances transparency through expanded reporting on research institutions and award demographics, and creates safeguards to prevent foreign-controlled entities from participating. The bill benefits small businesses seeking federal R&D funding and aims to broaden participation among underrepresented groups, women-owned firms, and institutions in underserved states.

Why we flagged it

The bill's core function is to extend and enhance federal SBIR/STTR programs through 2030, increase agency spending allocations, and improve commercialization support. It is a straightforward reauthorization with modernizing amendments, not a deregulation, subsidy carve-out, or commemorative measure.

What the text implies

• The mandatory 10% fund transfer from major agencies (DoD, DOE, HHS, NASA, NSF) to SBA for SBIR/STTR administration may reduce those agencies' discretionary R&D budgets and could shift control over innovation priorities toward the SBA.
• Section 505's foreign-entity safeguards, while security-focused, may inadvertently exclude legitimate small businesses with foreign investors or international research partnerships, potentially narrowing the talent pool and innovation sources.
• The commercialization impact assessment (Section 506) creates a 9-year tracking requirement that may burden small firms with reporting obligations and could be used to justify future program restrictions if commercialization rates fall short of expectations.
• The NIH pilot program (Section 504) to accelerate awards to 90 days may create pressure on peer-review quality and could disadvantage proposals requiring longer evaluation periods for complex scientific merit assessment.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to federal R&D funding for small businesses, particularly those owned by women and socially disadvantaged individuals, while strengthening transparency and oversight. The foreign-entity safeguards protect national security interests. However, the gradual increase in agency spending obligations (4% to 7%) may create budget pressures on participating agencies, and the foreign-ownership restrictions could limit some legitimate international partnerships.

Who stands to gain

• small businesses participating in SBIR/STTR programs
• women-owned small businesses
• socially and economically disadvantaged small business owners
• small businesses in underserved states
• minority institutions and Hispanic-serving institutions (as research partners)
• nonprofit organizations providing fellowship and outreach services

Named in the bill

Small Business Administration (SBA), Small Business Innovation Research (SBIR) Program, Small Business Technology Transfer (STTR) Program, National Institutes of Health (NIH), Department of Defense (DoD), Department of Energy (DoE), Department of Health and Human Services (HHS), National Aeronautics and Space Administration (NASA), National Science Foundation (NSF), General Services Administration (GSA), Comptroller General, Small Business Investment Companies (SBICs)

Where it stands

3 cosponsors: 3 Democrats.

• May 1, 2025 — Introduced · Congress.gov: “Introduced in House”
• May 1, 2025 — Referred to House Committee on Science, Space, and Technology and House Committee on Small Business · Congress.gov: “Referred to the Committee on Small Business, and in addition to the Committee on Science, Space, and…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $2,748,000 in lobbying spend. A filing names 12 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Nydia Velázquez, the sponsor, reported $62,000 in PAC receipts in the 2026 cycle.

• Biotechnology Innovation Organization — $2,360,000 on 1 filing
• Association for Uncrewed Vehicle Systems International — $228,000 on 2 filings
• Boston University — $50,000 on 1 filing
• Activate Global, Inc. — $40,000 on 1 filing
• Venturewell — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.